Daiichi Sankyo Company, Limited

TSE:4568 Stock Report

Market Cap: JP¥7.3t

Daiichi Sankyo Company Balance Sheet Health

Financial Health criteria checks 6/6

Daiichi Sankyo Company has a total shareholder equity of ¥1,623.4B and total debt of ¥101.3B, which brings its debt-to-equity ratio to 6.2%. Its total assets and total liabilities are ¥3,456.1B and ¥1,832.7B respectively. Daiichi Sankyo Company's EBIT is ¥331.9B making its interest coverage ratio -14.9. It has cash and short-term investments of ¥639.8B.

Key information

6.24%

Debt to equity ratio

JP¥101.33b

Debt

Interest coverage ratio-14.9x
CashJP¥639.84b
EquityJP¥1.62t
Total liabilitiesJP¥1.83t
Total assetsJP¥3.46t

Recent financial health updates

Recent updates

Daiichi Sankyo Company, Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Apr 30
Daiichi Sankyo Company, Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Is Daiichi Sankyo Company (TSE:4568) Using Too Much Debt?

Apr 06
Is Daiichi Sankyo Company (TSE:4568) Using Too Much Debt?

Daiichi Sankyo Company, Limited's (TSE:4568) P/E Is On The Mark

Feb 26
Daiichi Sankyo Company, Limited's (TSE:4568) P/E Is On The Mark

Daiichi Sankyo Company, Limited Just Recorded A 8.3% EPS Beat: Here's What Analysts Are Forecasting Next

Feb 04
Daiichi Sankyo Company, Limited Just Recorded A 8.3% EPS Beat: Here's What Analysts Are Forecasting Next

Daiichi Sankyo Company, Limited's (TSE:4568) Intrinsic Value Is Potentially 93% Above Its Share Price

Jan 14
Daiichi Sankyo Company, Limited's (TSE:4568) Intrinsic Value Is Potentially 93% Above Its Share Price

Daiichi Sankyo Company, Limited's (TSE:4568) Share Price Matching Investor Opinion

Nov 25
Daiichi Sankyo Company, Limited's (TSE:4568) Share Price Matching Investor Opinion

Daiichi Sankyo Company's (TSE:4568) Solid Earnings Are Supported By Other Strong Factors

Nov 07
Daiichi Sankyo Company's (TSE:4568) Solid Earnings Are Supported By Other Strong Factors
author-image

Antibody-Drug Innovation And Strategic Partnerships Pave The Way For Significant Growth

Strategic R&D investments in antibody-drug conjugates and collaborations indicate potential future revenue growth and enhanced market share in oncology.

Daiichi Sankyo Company, Limited Just Recorded A 223% EPS Beat: Here's What Analysts Are Forecasting Next

Nov 04
Daiichi Sankyo Company, Limited Just Recorded A 223% EPS Beat: Here's What Analysts Are Forecasting Next

Daiichi Sankyo Company (TSE:4568) Is Due To Pay A Dividend Of ¥30.00

Sep 22
Daiichi Sankyo Company (TSE:4568) Is Due To Pay A Dividend Of ¥30.00

Financial Position Analysis

Short Term Liabilities: 4568's short term assets (¥1,909.4B) exceed its short term liabilities (¥754.0B).

Long Term Liabilities: 4568's short term assets (¥1,909.4B) exceed its long term liabilities (¥1,078.7B).


Debt to Equity History and Analysis

Debt Level: 4568 has more cash than its total debt.

Reducing Debt: 4568's debt to equity ratio has reduced from 17.2% to 6.2% over the past 5 years.

Debt Coverage: 4568's debt is well covered by operating cash flow (53.1%).

Interest Coverage: 4568 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/29 04:41
End of Day Share Price 2025/05/29 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Daiichi Sankyo Company, Limited is covered by 30 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Atsushi SekiBarclays
null nullBNP Paribas Securities (Asia)
Koichi MameganoBofA Global Research